p53 tumor supresor gene in digestive cancer

被引:0
作者
Roa, JC
Roa, I
Araya, JC
Villaseca, MA
Melo, A
Burgos, L
机构
[1] Univ La Frontera, Fac Med, Hosp Reg Temuco, Unidad Anat Patol,Serv Cirugia, Temuco, Chile
[2] Univ La Frontera, Fac Med, Hosp Reg Temuco, Unidad Anat Patol,Dept Cirugia, Temuco, Chile
关键词
genes; p53; genetic markers; genetic predisposition to disease; digestive system neoplasm;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant diseases of the digestive tract cause more than 50% of deaths due to cancer in Chile. There is a high incidence of gastric and gallbladder cancer and an increasing frequency of colorectal cancer. P53 tumor suppressor gene has a great importance in carcinogenesis and its alterations are specially important in digestive tract tumors such as colorectal cancer. There is contradictory evidence about the frequency of p53 gene or protein alterations or their biological significance. There is little information about p53 in Chile and it is mostly limited to immunohistochemical studies. This revision analyzes the frequency of p53 alterations in digestive tract tumors in Chile, using immunohistochemical and molecular biology methods. A special emphasis is given to the prognostic importance of this gene (Rev Med Chile 2000; 128: 1269-78).
引用
收藏
页码:1269 / 1278
页数:10
相关论文
共 89 条
  • [1] Ajiki T, 1996, HEPATO-GASTROENTEROL, V43, P521
  • [2] Aranda M, 1998, REV MED CHILE, V126, P525
  • [3] ARAYA JC, 1989, REV MED CHILE, V117, P773
  • [4] BENNETT WP, 1992, CANCER RES, V52, P6092
  • [5] Cooccurrence of reduced expression of α-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer
    Che, XM
    Hokita, S
    Natsugoe, S
    Tanabe, G
    Baba, M
    Takao, S
    Kuroshima, K
    Aikou, T
    [J]. ONCOLOGY, 1999, 57 (02) : 131 - 137
  • [6] Diagnostic p53 expression in gastric endoscopic mucosal resection
    Cho, JH
    Roe, IH
    Jin, YJ
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (04) : 412 - 416
  • [7] Coggi G, 1997, CANCER, V79, P425, DOI 10.1002/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO
  • [8] 2-H
  • [9] CSENDES A, 1992, REV MED CHILE, V120, P36
  • [10] CUNNINGHAM J, 1992, CANCER RES, V52, P1974